Clinical Trial Results of eBalance®
In a study approved by Health Canada, eBalance® underwent a rigorous 12-week observational clinical trial, focusing on its efficacy and safety for diabetic patients.
Thirty participants, all diagnosed with diabetes, were selected to partake in this study twice weekly for fifteen minutes per treatment. The objective was clear: to observe and record the effects of eBalance® on key health parameters, including blood pressure, plasma insulin levels, and fasting blood sugar levels.
Here are the findings that mark a significant milestone in anti-aging, diabetic care and electroceutical intervention.
Blood Pressure (Hypertension)
The trial demonstrated a promising trend towards the reduction of blood pressure among the participants. Both systolic and diastolic blood pressure readings showed a mean decrease from the baseline measurement with a mean of 142 mmHg and 78 mmHg respectively to a measurement at end of study with a mean of 128 mmHg and 70 mmHg.
Notably, this decrease was not abrupt but followed a gradual trajectory, with the most significant changes observed from weeks one through seven.
Post the seventh week, the decrease in blood pressure plateaued, maintaining a steady and improved state until the study’s conclusion at week twelve. This pattern indicates not just an immediate response to the treatment but also its sustained efficacy over time.
Blood Pressure Analysis (30 participants)
Status | Baseline (Pre-Trial) | End of Study (EOS) |
---|---|---|
Over 140/90 mmHg | 18 (60%) | 7 (23%) |
Under 140/90 mmHg | 12 (40%) | 23 (77%) |
Blood Pressure Trend at End of Study (EOS)
Trend | Number of Subjects | Percentage |
---|---|---|
Lower at EOS | 24 | 80% |
Higher at EOS | 3 | 10% |
Even at EOS | 3 | 10% |
Importance – Maintaining healthy blood pressure is crucial for overall health and well-being, as high blood pressure (hypertension) can lead to serious health issues. Hypertension is often referred to as a “silent killer” because it typically has no symptoms but can cause long-term damage to the body. Here are the key reasons why avoiding high blood pressure is important:
Plasma Insulin
One of the most remarkable outcomes of the study was observed in the plasma insulin levels of the participants. With the baseline average being 168 pmol/L, within the healthy range but close to the upper limit, the treatment exhibited a profound impact.
By the study’s end, the plasma insulin levels had plummeted by an impressive 48%, averaging at 86 pmol/L. This significant reduction underscores the potential of eBalance® in regulating insulin levels.
Plasma Insulin Analysis (24 participants)
Note: Only 24 subjects are included due to insufficient data for 2 subjects and Type I diabetes for 4 subjects..
Status | Baseline (Pre-Trial) | End of Study (EOS) |
---|---|---|
Over 174 pmol/L | 11 (46%) | 4 (17%) |
Under 174 pmol/L | 13 (54%) | 20 (83%) |
Plasma Insulin Trend at End of Study
Trend | Number of Subjects | Percentage |
---|---|---|
Lower at EOS | 20 | 83% |
Higher at EOS | 4 | 17% |
Importance – It is important to note that there is research to suggest that lower insulin levels are associated with increased lifespan and improved healthspan, possibly due to reduced metabolic stress and decreased risk of chronic diseases.
In addition, high insulin levels are often associated with increased levels of inflammation in the body, which can lead to chronic diseases. Lowering insulin levels can reduce inflammation and improve overall health. Here are more reasons to reduce high plasma insulin levels:
Fasting Blood Sugar
Fasting blood sugar levels, a critical indicator of glycemic control, were also meticulously monitored during the trial. Pre-trial, the average fasting blood sugar level of the participants stood at a concerning 10.5 mmol/L, well into the diabetic range.
Over the 12-week period, eBalance® showcased its therapeutic potential by reducing the average fasting blood sugar levels to 9.2 mmol/L a 12% decrease. Although still in the diabetic range, this reduction is indicative of a positive trend and, most importantly, a step towards better glycemic control.
Importance – Maintaining low fasting blood sugar levels is vital for overall health, particularly in preventing and managing diabetes and its associated complications. Here’s why keeping fasting blood sugar levels within a healthy range is important:
Safety and Tolerability:
Throughout the 12-week period, eBalance® treatment was observed to be safe for all participants, with no significant adverse events reported. This aspect of the study highlights the device’s potential for safe integration into regular health and wellness routines.
Conclusion:
The clinical trial of eBalance® marks a pivotal advancement in the home management and treatment of aging related complications. With the backing of Health Canada and the promising results from this trial, eBalance® stands at the cusp of transforming wellness treatment paradigms, ushering in a future where electroceutical solutions are a cornerstone of aging management and potentially a crucial factor in enhanced longevity.
© 2024 StimCell Energetics — All Rights Reserved